Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Aug;7(8):1182-90.
doi: 10.4161/cbt.7.8.6215. Epub 2008 Aug 1.

A novel role for mitochondria in regulating epigenetic modification in the nucleus

Affiliations

A novel role for mitochondria in regulating epigenetic modification in the nucleus

Dominic J Smiraglia et al. Cancer Biol Ther. 2008 Aug.

Abstract

Epigenetic modification in the nuclear genome plays a key role in human tumorigenesis. In this paper, we investigated whether changes in the mtDNA copy number frequently reported to vary in a number of human tumors induce methylation changes in the nucleus. We utilized the Restriction Landmark Genomic Scanning (RLGS) to identify genes that undergo changes in their methylation status in response to the depletion and repletion of mtDNA. Our study demonstrates that depletion of mtDNA results in significant changes in methylation pattern of a number of genes. Furthermore, our study suggests that methylation changes are reversed by the restoration of mtDNA in cells otherwise lacking the entire mitochondrial genome. These studies provide the first direct evidence that mitochondria regulate epigenetic modification in the nucleus that may contribute to tumorigenesis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mitochondrial COXII expression in rho0 and cybrid cells. Western blot analysis of expression of subunit II of respiratory chain enzyme complex IV (cytochrome c oxidase: COX II) in cultured cells lacking mtDNA (rho0 cells) derived either chemically (A) or genetically after transfection of parental cells with HSV UL12.5 gene (B) characterized by absence of mtDNA encoded COXII expression. Repopulation of 143B rho0 cells with human platelet mitochondria resulted in reexpression of COX II expression level in cybrids cells. The tubulin antibody was used as a loading control.
Figure 2
Figure 2
Aberrant CpG island methylation in rho0 cells. Representative examples of RLGS analysis are shown comparing three parental cell lines to their corresponding rho0 cell lines. RLGS spots of interest are shown by solid-line circles to indicate presence of the spot (lack of methylation), while dashed-line circles indicate absence of a spot (methylation). (A) MCF12A cell-line showing spots 1 and 2 exhibiting hypermethylation in the rho0 cell line and spot 3 exhibiting hypomethylation in the rho0 cell line. (B) MDA-MB-435 cell line showing spot 1 and 2 exhibiting hypermethylation in the rho0 cell line. (C) 143B cell line showing RLGS spot 2E58 exhibiting hypomethylation in the rho0 cell line. (D) Bisulfite-sequencing of 2E58 from both the 143B parental and rho0 cell lines. Four clones each were sequenced across a 285 bp region containing 34 CpG dinucleotides. Each horizontal line of circles represents the sequencing data from an individual clone. Each circle represents one CpG: closed circle = methylation; open circle = no methylation.
Figure 3
Figure 3
Figure 3. (A–C) Reversal of aberrant CpG island methylation in cybrid cell-line. (A) Representative examples of RLGS analysis are shown comparing spot 4B15 in the 143B parental, genetically engineered rho0 cell line, and cybrid cell lines. The dashed-line circle indicates methylation of 4B15 in the parental line, while the solid-line circles indicate partial hypomethylation of 4B15 in both the rho0 and cybrid lines. (B) Smoothed-line graph of Mass Array Quantitative Methylation Analysis (MAQMA) data for 4B15. The level of methylation at each informative CpG dinucleotide is shown. CpGs 3, 4 and 9 were non-informative because of inappropriate fragment size for MALDI-TOF detection. The left panel shows the results on control DNAs with the indicated ratio of in vitro methylated (IVM) DNA. The right panel shows the results of the three cell-lines, with both the rho0 and the cybrid lines showing hypomethylation relative to the parental line. (C) Representative examples of RLGS analysis comparing spot 5C32 in the 143B parental, genetically rho0 and cybrid cell-lines. The dashed-line circle indicates partial methylation of 5C32 in both the parental and cybrid lines, while the solid-line circle indicates hypomethylation of 4B15 in the rho0 cell line. Figure 3. (D and E) Reversal of aberrant CpG island methylation in cybrid cell-line. (D) Smoothed-line graph of MAQMA data for 5C32. The level of methylation at each of 20 CpG dinucleotides is shown. The top panel shows the results on control DNAs with the indicated ratio of in vitro methylated (IVM) DNA. The bottom panel shows the results of the three cell-lines, with the rho0 cell line showing hypomethylation relative to the parental line and cybrid lines, except at CpGs 9–11. (E) Histograph analysis of MAQMA data. To obtain a single value for each locus in each cell-line, the average level of methylation at which all informative CpG dinucleotides for 4B15 and 5C32 were calculated is shown.
Figure 3
Figure 3
Figure 3. (A–C) Reversal of aberrant CpG island methylation in cybrid cell-line. (A) Representative examples of RLGS analysis are shown comparing spot 4B15 in the 143B parental, genetically engineered rho0 cell line, and cybrid cell lines. The dashed-line circle indicates methylation of 4B15 in the parental line, while the solid-line circles indicate partial hypomethylation of 4B15 in both the rho0 and cybrid lines. (B) Smoothed-line graph of Mass Array Quantitative Methylation Analysis (MAQMA) data for 4B15. The level of methylation at each informative CpG dinucleotide is shown. CpGs 3, 4 and 9 were non-informative because of inappropriate fragment size for MALDI-TOF detection. The left panel shows the results on control DNAs with the indicated ratio of in vitro methylated (IVM) DNA. The right panel shows the results of the three cell-lines, with both the rho0 and the cybrid lines showing hypomethylation relative to the parental line. (C) Representative examples of RLGS analysis comparing spot 5C32 in the 143B parental, genetically rho0 and cybrid cell-lines. The dashed-line circle indicates partial methylation of 5C32 in both the parental and cybrid lines, while the solid-line circle indicates hypomethylation of 4B15 in the rho0 cell line. Figure 3. (D and E) Reversal of aberrant CpG island methylation in cybrid cell-line. (D) Smoothed-line graph of MAQMA data for 5C32. The level of methylation at each of 20 CpG dinucleotides is shown. The top panel shows the results on control DNAs with the indicated ratio of in vitro methylated (IVM) DNA. The bottom panel shows the results of the three cell-lines, with the rho0 cell line showing hypomethylation relative to the parental line and cybrid lines, except at CpGs 9–11. (E) Histograph analysis of MAQMA data. To obtain a single value for each locus in each cell-line, the average level of methylation at which all informative CpG dinucleotides for 4B15 and 5C32 were calculated is shown.

Comment in

  • Mitochondrial control of epigenetics.
    Naviaux RK. Naviaux RK. Cancer Biol Ther. 2008 Aug;7(8):1191-3. doi: 10.4161/cbt.7.8.6741. Epub 2008 Aug 4. Cancer Biol Ther. 2008. PMID: 18719362 No abstract available.

References

    1. Warburg O. On respiratory impairment in cancer cells. Science. 1956;124:269–70. - PubMed
    1. Damiani S, Dina R, Eusebi V. Eosinophilic and granular cell tumors of the breast. Semin Diagn Pathol. 1999;16:117–25. - PubMed
    1. Damiani S, Eusebi V, Losi L, D'Adda T, Rosai J. Oncocytic carcinoma (malignant oncocytoma) of the breast. Am J Surg Pathol. 1998;22:221–30. - PubMed
    1. Singh KK. Mitochondrial DNA mutations in aging, disease and cancer. New York, USA: Springer; 1998.
    1. Singh KK, Russell J, Sigala B, Zhang Y, Williams J, Keshav KF. Mitochondrial DNA determines the cellular response to cancer therapeutic agents. Oncogene. 1999;18:6641–6. - PubMed

Publication types

LinkOut - more resources